| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/22/2004 | US20040142936 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142923 inhibitors of urotensin II |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142900 polypeptide with the transport function of herpesviral VP22 protein and which can regulate cell cycle progression, e.g. proteins which can induce apoptosis, or proteins which can arrest cells from the cell cycle to arrest cell proliferation |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142418 Novel neurotrophic factors |
| 07/22/2004 | US20040142379 using proteomica and combinatorial chemistry for drug screening/design/targets; libraries; solid phase synthesis |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142094 Method for coating medical devices |
| 07/22/2004 | US20040142005 treating a cardiovascular disease, especially preventing restenosis in a blood vessel which may occur following a cardiovascular procedure, |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141917 Antibodies to truncated VEGF-D and uses thereof |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | DE202004003714U1 New phenyl maleic anhydride and maleimide derivatives used for lowering blood pressure, increasing high-density lipoprotein or as central cholinergic agonists, hepatoprotective, antiinflammatory agents and antitumor agents |
| 07/22/2004 | CA2506719A1 Treatment of chronic heart failure |
| 07/22/2004 | CA2455832A1 Method for dip coating medical devices with an aqueous latex polymeric emulsion |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439187A1 O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 07/21/2004 | EP1439178A1 HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1439175A1 Pyrimidine compound and medicinal composition thereof |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438972A1 Remedy for ischemic heart failure |
| 07/21/2004 | EP1438942A1 An otorhinological drug delivery device |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438392A2 Cell populations which co-express cd49c and cd90 |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438309A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 07/21/2004 | EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438297A1 Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1438285A1 Acetic acid derivatives |
| 07/21/2004 | EP1438283A1 Dicarboxylic acid derivatives, their preparation and therapeutic use |
| 07/21/2004 | EP1438281A2 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438065A2 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions |
| 07/21/2004 | EP1438060A2 Prevention and treatment of restenosis by local administration of drug |
| 07/21/2004 | EP1438055A1 D-tagatose as an anti-biofilm agent |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 07/21/2004 | EP1438049A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438043A2 Method of reducing type 2 diabetes in high risk patients |
| 07/21/2004 | EP1438038A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 07/21/2004 | EP1438027A1 Methods of treatment using a gastric retained losartan dosage |
| 07/21/2004 | EP1351942B1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0999843B1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514839A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds |
| 07/21/2004 | CN1514838A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds |
| 07/21/2004 | CN1514837A 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds |
| 07/21/2004 | CN1514836A New process for preparation of oxabispidines |
| 07/21/2004 | CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 07/21/2004 | CN1514834A Cyclohexylphenyl vasopression agonists |
| 07/21/2004 | CN1514823A 草酸衍生物 Oxalic acid derivatives |
| 07/21/2004 | CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1514242A Quality control method of injection agent for treating apoplexia |
| 07/21/2004 | CN1513991A Recombination human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1513832A Propanol amine kind ether compound synthesized using paeonol as mather body and its derivative |
| 07/21/2004 | CN1513831A Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative |
| 07/21/2004 | CN1513544A Medicine for treating cranial vascular disease |
| 07/21/2004 | CN1513542A Chinese medicinal preparation for treating viral myocarditis and its making method |
| 07/21/2004 | CN1513541A Compound ginkgo leaf reparation and its making method |
| 07/21/2004 | CN1513535A Chinese medicinal preparation for treating coronarg heart disease arrhythmia and its manufacturing process |
| 07/21/2004 | CN1513522A Chiese patent drug for treating apoplexia and its preparation method |
| 07/21/2004 | CN1513502A Medicine for treating chronic and acute cardiomyopathy |
| 07/21/2004 | CN1513495A Ginkgo leaf extraction injection for treating ischemic cerebral apoplexia and its prepn. method |
| 07/21/2004 | CN1513494A Traditional chinese medicine composition for treating coronary heart disease and angina pectoris |
| 07/21/2004 | CN1513492A Herbal medicine for treating hypertension disease, and its prepn. method |
| 07/21/2004 | CN1513485A Medicine for treating hypertension |
| 07/21/2004 | CN1513479A Method for producing ointmen for treating hemorrhoids |